After this election it's safe to say 'Big Data' has become a buzzworthy word. But where to next? Last week, Canada's data warehouse, TH!NK announced it will be merging Business Insights and Big Data.
Employing a state-of-the-art, Oracle-based data warehouse, TH!NK will launch its first offering, TH!NK Sales, in January of 2013. This product will track shipment data from manufacturers and wholesalers to pharmacy outlets and hospitals.
This type of collaboration could potentially produce real time data, trend alerts, efficient verification methods, and the ability to access information from many locations. It will offer valuable insights into sales trends and market share with improved speed, reliability and value. Planned future solutions will include prescribing trends, drug utilization insights and related analysis imperative to stakeholders wishing to forecast, monitor resources and plan drug development.
It is an information economy and the Life Science Industry has an abundance of information. With all of the technological advancements, how will big data change the pharmaceutical industry? And how will it help save time?
Using the powerful analytics to take this information to knowledge is a critical success factor for the industry’s future. How has the information become a key weapon in product development? Join us February 6-8 at the Data Driven Drug Development event where Astrazeneca’s Chief Technology Officer, Angela Yochem keynote session, Weapon of Mass Construction: How Life Science Information Management Facilitates Faster and Better Decision Making. For more information download our full brochure here.
As a reader of this blog, you’ll save 15% off the standard rate when you register to join us and mention code XP1715LINK!
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment